OM2 Abbreviated Sensor Verification
Verification of Investigational Pulse Oximetry Devices With the Abbreviated Sensor Line in Adult Volunteers
1 other identifier
observational
28
1 country
1
Brief Summary
The verification of an investigational pulse oximetry board to verify pulse rate and saturation accuracy over a specified saturation range in diverse populations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 22, 2024
CompletedFirst Submitted
Initial submission to the registry
April 19, 2024
CompletedFirst Posted
Study publicly available on registry
May 16, 2024
CompletedJuly 28, 2025
April 1, 2024
11 days
April 19, 2024
July 23, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Verification of Saturation Accuracy
Saturation accuracy in a diverse subject population over a specified saturation range. The acceptance criteria for the investigational Pulse Oximetry PCBA system, SpO2 across the saturation range of 70-100%: SpO2 Max-A ±2% (ARMS) OxySoft-N ±2% (ARMS) Max-Fast ±2% (ARMS) FlexMax ±2.5%(ARMS) DS-100A ±3% (ARMS) D-YS ±3% (ARMS)
2.5 hours
Verification of Pulse Rate
Pulse rate in a diverse subject population over a specified saturation range. The acceptance criteria for pulse rate from 20-250 BPM over a specified saturation range of 70-100%: Pulse Rate Max-A ≤3% BPM (ARMS) OxySoft-N ≤3% BPM (ARMS) Max-Fast ≤3% BPM (ARMS) FlexMax ≤3% BPM (ARMS) DS-100A ≤3% BPM (ARMS) D-YS ≤3% BPM (ARMS)
2.5 hours
Study Arms (1)
Healthy Volunteers
Eligibility Criteria
Healthy Male or Female volunteers age 18 to 50 years, weighing greater than 40kgs. Volunteers must be non-smokers or not smoked within 2 days prior to the study. Cleared a same day health assessment form and health screen to ensure none of the exclusion criteria was met. With a successful perfusion index ulnar/ulnar+radial ratio test showing adequate collateral blood flow.
You may qualify if:
- Male or female subjects 18 to 50 years of age
- Subject is willing and able to comply with study procedures and duration
- Subject is willing to sign an informed consent
- Subject weighs \>40kg
- Subject is a non-smoker or has not smoked within 2 days prior to the study
- Cleared same day health assessment form and health screening
- Successful perfusion index ulnar/ulnar+radial ratio test showing adequate collateral blood flow.
You may not qualify if:
- Subject is considered as being morbidly obese (defined as BMI \>39.5)
- Compromised circulation, injury, or physical malformation of fingers, hands, ears or forehead/skull or other sensor sites which would limit the ability to test sites needed for the study (Note: Certain malformations may still allow subjects to participate if the condition is noted and would not affect the sites utilized)
- Females of childbearing potential who are pregnant, who are trying to get pregnant, or who have a urine test positive for pregnancy on the day of the study
- Subjects with COHb levels \>3% as assessed by CO-Oximetry during the procedure
- tHb \< 10 g/dl as assessed by CO-Oximetry during the procedure
- MetHb ≥ 2% as assessed by CO-Oximetry during the procedure
- Subjects with known respiratory conditions such as:
- uncontrolled / severe asthma
- flu or influenza type infection
- pneumonia / bronchitis
- shortness of breath / respiratory distress
- unresolved respiratory or lung surgery
- emphysema, COPD, lung disease
- recent COVID (last 2 months)
- Subjects with known heart or cardiovascular conditions such as:
- +38 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medtronic - MITGlead
Study Sites (1)
Element
Louisville, Colorado, 80027, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Monica Rabanal
Element Labs
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 19, 2024
First Posted
May 16, 2024
Study Start
February 11, 2024
Primary Completion
February 22, 2024
Study Completion
February 22, 2024
Last Updated
July 28, 2025
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share